Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research (NCT07623668)
A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).
Who can join: Review the eligibility criteria below.
Location: Kahana Oculoplastic and Orbital Surgery — Livonia, Michigan
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Kahana Oculoplastic and Orbital Surgery — Livonia, Michigan
- Medical University of South Carolina, Storm Eye Institute — Charleston, South Carolina
- UT Southwestern Medical Center (Ophthalmology CRU) — Dallas, Texas
- Neuro-Eye Clinical Trials — Houston, Texas
📞 Contact the Study Coordinator
Phone: (617) 928-5886
Email: info@oculis.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Optic Neuritis
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) — San Francisco, California
- Efgartigimod for the Treatment of Acute Optic Neuritis — Boston, Massachusetts
- Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX) — Scottsdale, Arizona
Explore by condition: All Optic Neuritis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.